Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2019

View Archived Issues

Plaques form early, and differently, in Trem2-associated Alzheimer's disease

PD-1-Fc-OX40L fusion protein simultaneously blocks immune checkpoint pathways and activates TNFRs

PAMVAC vaccine demonstrates safety and immunogenicity in first-in-human study

Positive results presented for second cohort of phase II study of ZGN-1061

Microtubule polymerization inhibitor prodrugs identified at the University of Maryland

Daiichi Sankyo patents histone acetyltransferase p300/CREB-binding protein inhibitors

Gruenenthal presents new phosphodiesterase PDE4B inhibitors

Birdie Biopharmaceuticals discovers resiquimod salts

Promentis Pharmaceuticals initiates phase II studies of SXC-2023

APP's day job: amyloid precursor protein suppresses GABA transmission

Sarepta Therapeutics initiates phase II study of SRP-9001 in patients with DMD

YF-ZIKprM/E vaccine protects against Zika infection and congenital malformations in mouse models

MiR-20a/miR-106a identified as a therapeutic target for preventiing CRC progression

Patient enrollment ongoing in Roche's phase III study of RO-7234292 in Huntington's disease

NHS-IL-12 demonstrates safety and early clinical immune-related activity

AbbVie begins phase II trial of elezanumab for relapsing MS

Novartis begins first-in-human trial of NJH-395 in non-breast HER2-positive advanced malignancies

iJak-381 demonstrates efficacy in rodent models of asthma

FDA issues complete response letter for sacituzumab govitecan BLA for metastatic TNBC

T-PEP funding supports Aquinnah Pharmaceuticals work in tauopathies

Global Alliance for TB Drug Development begins phase I trial of TBI-223 in healthy subjects

CorMedix reports topline results from interim analysis of phase III trial of Neutrolin

U.S. clearances granted for phase III trial of ranibizumab biosimilar Xlucane

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...